Home > About > Management Team

Meet our management team

Our leadership team draws from a breadth of expertise and professional experiences to guide Veloxis in our corporate mission.

Our management team brings our vision to reality

At Veloxis, our leadership team draws from a depth of knowledge and experience on the clinical and commercial sides of the life sciences industry. Our leaders help us maintain a consistent vision for goal setting and organizational strategy. Get to know the Veloxis leadership team better by learning more about their backgrounds and professional experiences.

team image

Mark Hensley
Chief Executive Officer

Mark brings more than 15 years' experience in pharmaceutical sales and leadership positions to his role as Chief Executive Officer.

See full bio
team image

Tunde Otulana, MD
Chief Medical Officer

Dr. Otulana joined Veloxis in 2020, bringing more than 20 years of leadership experience in the pharmaceutical/biotech industry.

See full bio
team image

Ulf Meier-Kriesche, MD, FAST
Chief Scientific Officer

A board-certified nephrologist, Dr. Meier-Kriesche is a leader in transplant medicine, with more than 20 years’ practical experience in renal transplant.

See full bio
team image

Ed Sleeper
Chief Ethics and Compliance Officer

Ed is Chief Ethics and Compliance Officer at Veloxis, joining the organization in 2023.

See full bio
team image

Stacy Wheeler
Senior Vice President, Operations

With more than 20 years' experience managing global pharmaceutical supply chains, Stacy has successfully led Veloxis’s operations since 2016.

See full bio
team image

Noel Barnard
Vice President, Legal and General Counsel

Noel has led the Veloxis legal team since 2016 and is responsible for overseeing all aspects of Veloxis’s global legal affairs.

See full bio
team image

Daisuke Okajima
Vice President, Global Strategy & Planning

With more than 20 years’ experience in the pharmaceutical industry and a background in international business, Daisuke previously served as the liaison between Veloxis and Asahi Kasei and officially joined Veloxis in August 2020.

See full bio
team image

Steven G. Rizk, PharmD, JD
Vice President, Medical Affairs

An accomplished biopharma medical affairs executive with more than 20 years’ experience in the industry, Dr. Rizk joined Veloxis in August 2021 as Vice President of Medical Affairs.

See full bio
team image

Kamal Shah, MD, DA
Vice President, Pharmacovigilance

A trained anesthesiologist with practical experience, Dr. Shah joined Veloxis in April 2021 as Vice President of Pharmacovigilance and Safety.

See full bio
team image

Umang S. Shah, PhD, MBA, RAC, RPh
Vice President, Regulatory Affairs

Dr. Shah joined Veloxis in November 2021 as Vice President of Regulatory Affairs and brings over 25 years’ experience in the pharmaceutical industry as a scientist, research fellow, and regulatory expert.

See full bio

Now that you know us, we welcome the opportunity to work with you

Partner with us